# Phase III Randomized, Double-Blind, Placebo-Controlled Study of Antenatal Thyrotropin-Releasing Hormone in Pregnant Women With Threatened Premature Delivery

> **NCT00004778** · PHASE3 · COMPLETED · sponsor: **National Center for Research Resources (NCRR)** · enrollment: 1090 (—)

## Conditions studied

- Respiratory Distress Syndrome

## Interventions

- **DRUG:** betamethasone
- **DRUG:** dexamethasone
- **DRUG:** thyrotropin-releasing hormone

## Key facts

- **NCT ID:** NCT00004778
- **Lead sponsor:** National Center for Research Resources (NCRR)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1993-08
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 1090 (—)
- **Last updated:** 2005-06-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004778, "Phase III Randomized, Double-Blind, Placebo-Controlled Study of Antenatal Thyrotropin-Releasing Hormone in Pregnant Women With Threatened Premature Delivery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00004778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*